Doykos Named APhA Jacob W. Miller Award Winner
She is director of the Bristol-Myers Squibb Foundation, which works to promote health equity and improve the health outcomes of those disproportionately affected by serious conditions and diseases.
The American Pharmacists Association (APhA) Foundation will honor Patricia Mae Doykos, PhD, as the recipient of the 2018 APhA Foundation Jacob W. Miller Award, at the foundation's Contributors' Breakfast at the APhA2018 Annual Meeting and Exposition on Monday, March 19, 2018, in Nashville, Tennessee.
The award recognizes individuals who have advanced the APhA Foundation’s mission through involvement in its programs, support of its initiatives, or leadership in carrying out its mission. It was established in 2000 to honor Jacob Miller, who served as president of the APhA Foundation from 1991 to 2000.
Doykos is director of the Bristol-Myers Squibb Foundation, whose mission is to promote health equity and improve the health outcomes of populations disproportionately affected by serious diseases and conditions.
She works on communications, evaluation, organizational development, and strategy for the Bristol-Myers Squibb Foundation overall and leads 2 national grant programs, Specialty Care for Vulnerable Populations and Together on Diabetes: Communities Uniting to Meet America’s Diabetes Challenge. Doykos has also developed and led international and US grant-making and public-private partnership programs for global HIV/AIDS, women’s health, cancer, and serious mental illness. She chairs the board of the Center for Health Equity at Dartmouth-Geisel Medical School and serves on the board of Grantmakers in Health, the National Minority Quality Forum-Cancer Moonshot Diverse Communities Working Group, and the advisory boards of Georgetown New Strategies and The iF Foundation.
“On behalf of the team at the Bristol-Myers Squibb Foundation, I am very honored to receive the 2018 Jacob W. Miller Award," Doykos said in a statement.
"The APhA Foundation was the very first grantee of the Together on Diabetes initiative with the IMPACT Diabetes Program and set the standard for all of our other grantees in how to create truly transformative change in health care delivery, disease management support and patient activation and self-management of diabetes," she said. "This innovative project clearly demonstrated the critical role that pharmacists play in bringing high-quality care and support to high-risk and vulnerable populations in communities across the country.”
Prior to joining the Bristol-Myers Squibb Foundation in 2002, Doykos led international public affairs for the company’s infectious-disease franchise and cancer research and development.